NO20060973L - Pyridylderivater og deres anvendelse som tempeutiske midler - Google Patents

Pyridylderivater og deres anvendelse som tempeutiske midler

Info

Publication number: NO20060973L
Authority: NO; Norway
Prior art keywords: tempeutic; agents; pyridyl derivatives; mammal; formula
Prior art date: 2003-07-29

Application number

NO20060973A

Other languages

English (en)

Norwegian (no)

Inventor

Serguei Sviridov

Melwyn Abreo

Heinz W Gschwend

Vishnumurthy Kodumuru

Michael D Winther

Rajender Kamboj

Shaoyi Sun

Wenbao Li

Daniel F Harvey

Mikhail A Kondratenko

Shifeng Liu

Nagasree Chakka

Original Assignee

Xenon Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-29

Filing date

2006-02-28

Publication date

2006-04-27

2006-02-28 Application filed by Xenon Pharmaceuticals Inc filed Critical Xenon Pharmaceuticals Inc

2006-04-27 Publication of NO20060973L publication Critical patent/NO20060973L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

NO20060973A 2003-07-29 2006-02-28 Pyridylderivater og deres anvendelse som tempeutiske midler NO20060973L (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US49114003P	2003-07-29	2003-07-29
US49114103P	2003-07-30	2003-07-30
US49132203P	2003-07-30	2003-07-30
US49108003P	2003-07-30	2003-07-30
US49111603P	2003-07-30	2003-07-30
PCT/US2004/024542 WO2005011654A2 (fr)	2003-07-29	2004-07-29	Derives de pyridyle et utilisation de ceux-ci en tant qu'agents therapeutiques

Publications (1)

Publication Number	Publication Date
NO20060973L true NO20060973L (no)	2006-04-27

Family

ID=34120125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060973A NO20060973L (no)	2003-07-29	2006-02-28	Pyridylderivater og deres anvendelse som tempeutiske midler

Country Status (17)

Country	Link
US (3)	US7763618B2 (fr)
EP (1)	EP1651605B1 (fr)
JP (1)	JP4884219B2 (fr)
KR (1)	KR20060036105A (fr)
AT (1)	ATE556056T1 (fr)
AU (1)	AU2004261250B2 (fr)
BR (1)	BRPI0413059A (fr)
CA (1)	CA2533898A1 (fr)
EC (1)	ECSP066314A (fr)
ES (1)	ES2386354T3 (fr)
IL (1)	IL173397A0 (fr)
MA (1)	MA28012A1 (fr)
MX (1)	MXPA06001202A (fr)
NO (1)	NO20060973L (fr)
SG (1)	SG145695A1 (fr)
TN (1)	TNSN06035A1 (fr)
WO (1)	WO2005011654A2 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7494999B2 (en)	2004-10-29	2009-02-24	Kalypsys, Inc	Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7517884B2 (en)	1998-03-30	2009-04-14	Kalypsys Inc.	Sulfonyl-substituted bicyclic compounds as modulators of PPAR
DE602004021206D1 (de) *	2003-07-24	2009-07-02	Euro Celtique Sa	Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
KR20060036105A (ko)	2003-07-29	2006-04-27	제논 파마슈티칼스 인크.	피리딜 유도체 및 그의 치료제로서의 용도
EP1651606B1 (fr) *	2003-07-30	2012-10-24	Xenon Pharmaceuticals Inc.	Derives pyridyle et leur utilisation en tant qu'agents therapeutiques
EP1830837B1 (fr)	2004-09-20	2013-09-04	Xenon Pharmaceuticals Inc.	Derives heterocycliques pour le traitement de maladies induites par des enzymes stearoyl-coadesaturases
JP5149009B2 (ja) *	2004-09-20	2013-02-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
CN101090724A (zh) *	2004-09-20	2007-12-19	泽农医药公司	用于抑制人硬脂酰CoA去饱和酶的吡啶衍生物
AU2005286728A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
AR051090A1 (es)	2004-09-20	2006-12-20	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
MX2007003325A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa.
AR051093A1 (es)	2004-09-20	2006-12-20	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de estearoil-coa desaturasa
MX2007003332A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
US7547698B2 (en) *	2004-09-20	2009-06-16	Xenon Pharmaceuticals Inc.	Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
WO2006058649A1 (fr) *	2004-12-03	2006-06-08	F. Hoffmann-La Roche Ag	Derives 3-substitues de pyridine en tant qu'antagonistes de h3
BRPI0517032A (pt) *	2004-12-16	2008-09-30	Hoffmann La Roche	compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e utilização desses compostos
EP1866314B1 (fr) *	2005-02-16	2010-09-15	NeuroSearch A/S	Derives aryle diazabicycliques et utilisation medicale
WO2006125180A1 (fr) *	2005-05-19	2006-11-23	Xenon Pharmaceuticals Inc.	Derives de piperazine: utilisation comme agents therapeutiques
WO2006125179A1 (fr) *	2005-05-19	2006-11-23	Xenon Pharmaceuticals Inc.	Composes tricycliques: utilisation comme agents therapeutiques
WO2006125194A2 (fr) *	2005-05-19	2006-11-23	Xenon Pharmaceuticals Inc.	Derives de piperazine et leurs utilisations en tant qu'agents therapeutiques
EP2029138A1 (fr)	2005-06-03	2009-03-04	Xenon Pharmaceuticals Inc.	Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine
WO2007051095A1 (fr)	2005-10-25	2007-05-03	Kalypsys, Inc.	Sels de modulateurs de ppar et procedes de traitement de troubles metaboliques
WO2007071023A1 (fr) *	2005-12-20	2007-06-28	Merck Frosst Canada Ltd.	Composés hétéroaromatiques en tant qu'inhibiteurs de stéaroyl-coenzyme a delta-9 désaturase
JP2009526059A (ja)	2006-02-07	2009-07-16	ワイス	１１−ベータｈｓｄ１阻害剤
PT2029572E (pt)	2006-06-05	2011-02-09	Novartis Ag	Compostos orgânicos
CN101506203B (zh)	2006-08-24	2013-10-16	诺瓦提斯公司	治疗代谢病、心血管病和其他病症的作为硬脂酰辅酶a脱饱和酶(scd)抑制剂的2-(吡嗪-2-基)-噻唑和2-(1h-吡唑-3-基)-噻唑衍生物及相关化合物
AU2007323193A1 (en) *	2006-11-20	2008-05-29	Glenmark Pharmaceuticals S.A.	Acetylene derivatives as Stearoyl CoA Desaturase inhibitors
US7638541B2 (en)	2006-12-28	2009-12-29	Metabolex Inc.	5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US20080176861A1 (en)	2007-01-23	2008-07-24	Kalypsys, Inc.	Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
US8575167B2 (en)	2007-02-06	2013-11-05	Takeda Pharmaceutical Company Limited	Spiro compounds having stearoyl-CoA desaturase action
ES2571533T3 (es) *	2007-04-27	2016-05-25	Purdue Pharma Lp	Antagonistas de TRPV1 y usos de los mismos
WO2008157844A1 (fr)	2007-06-21	2008-12-24	Forest Laboratories Holdings Limited	Nouveaux dérivés de pipérazine en tant qu'inhibiteurs de stéaroyl-coa désaturase
EP2185544B1 (fr)	2007-07-19	2014-11-26	Cymabay Therapeutics, Inc.	Derives subtitues heterocycliques a liaison n de pyrrole, pyrazole, imidazole, triazole et tetrazole comme agonistes de recepteurs rup3 ou gpr119 utilises dans le traitement du diabete et des troubles metaboliques
ES2352098T3 (es)	2007-08-08	2011-02-15	Graceway Pharmaceuticals, Llc	Derivado de fenoxi-pirrolidina y su uso y composiciones.
WO2009037542A2 (fr)	2007-09-20	2009-03-26	Glenmark Pharmaceuticals, S.A.	Composés spirocycliques en tant qu'inhibiteurs de stéaroyle coa désaturase
AU2009271414A1 (en) *	2008-06-20	2010-01-21	Metabolex, Inc.	Aryl GPR119 agonists and uses thereof
AU2010215035B2 (en)	2009-02-17	2014-06-12	Merck Canada Inc.	Novel spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase
WO2011011872A1 (fr)	2009-07-28	2011-02-03	Merck Frosst Canada Ltd.	Nouveaux composés spiro utiles en tant qu'inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
WO2011030312A1 (fr)	2009-09-10	2011-03-17	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Nouveaux inhibiteurs de stearoyl-coa-desaturase-1 et leurs utilisations
EP2483281B1 (fr)	2009-10-01	2014-06-04	Cymabay Therapeutics, Inc.	Sels de la tétrazol-1-yl-phénoxyméthyl-thiazol-2-yl-pipéridinyl-pyrimidine substituée
BR112012032248A2 (pt)	2010-06-23	2016-09-13	Metabolex Inc	composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
ES2620528T3 (es)	2011-06-22	2017-06-28	Purdue Pharma Lp	Antagonistas de TRPV1 que incluyen un sustituyente dihidroxi y usos de los mismos
EP2852387A2 (fr)	2012-05-22	2015-04-01	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Inhibiteurs sélectifs de cellules indifférenciées
CN105596291B (zh) *	2014-11-24	2020-09-08	辽宁海思科制药有限公司	一种磺达肝癸钠注射液组合物
WO2018026890A1 (fr)	2016-08-03	2018-02-08	Cymabay Therapeutics	Composés d'aryle d'oxyméthylène pour le traitement de maladies gastro-intestinales inflammatoires ou de troubles gastro-intestinaux
US11970486B2 (en)	2016-10-24	2024-04-30	Janssen Pharmaceutica Nv	Compounds and uses thereof
AU2018205275B2 (en)	2017-01-06	2024-05-02	Janssen Pharmaceutica Nv	Methods for the treatment of neurological disorders
US11873298B2 (en)	2017-10-24	2024-01-16	Janssen Pharmaceutica Nv	Compounds and uses thereof
AU2018354972B2 (en)	2017-10-27	2021-07-08	Fresenius Kabi Oncology Ltd.	An improved process for the preparation of ribociclib and its salts
AU2019238326B2 (en)	2018-03-23	2025-03-06	Janssen Pharmaceutica Nv	Compounds and uses thereof
KR20220007845A (ko)	2019-01-24	2022-01-19	유마니티 테라퓨틱스, 인크.	화합물 및 이의 용도
EA202192047A1 (ru)	2019-11-13	2021-12-08	Юманити Терапьютикс, Инк.	Соединения и их применение

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000044743A1 (fr) *	1999-01-28	2000-08-03	Nippon Shinyaku Co., Ltd.	Derives d'amides et compositions de medicaments
DE60006213T2 (de) *	1999-01-29	2004-07-29	Abbott Laboratories, Abbott Park	Diazabicyloderivate als nikotin-acetylcholin-rezeptorliganden
CA2369103A1 (fr)	1999-04-09	2000-10-19	Meiji Seika Kaisha, Ltd.	Composes heterocycliques contenant de l'azote et composes de benamide et medicaments contenant ces composes
US6677452B1 (en) *	1999-09-30	2004-01-13	Lion Bioscience Ag	Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof
ATE475718T1 (de) *	2000-02-24	2010-08-15	Xenon Pharmaceuticals Inc	Stearoyl-coa-desaturase zur identifizierung von triglyceridreduktionstherapeutika
GB0013383D0 (en)	2000-06-01	2000-07-26	Glaxo Group Ltd	Therapeutic benzamide derivatives
DE60130771T2 (de) *	2000-07-27	2008-07-17	Eli Lilly And Co., Indianapolis	Substituierte heterocyclische amide
MY136316A (en) *	2001-02-13	2008-09-30	Sanofi Aventis Deutschland	Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical.
JP2004532856A (ja) *	2001-04-30	2004-10-28	藤沢薬品工業株式会社	アポリポタンパク質ｂ阻害剤としてのビアリールカルボキサミド化合物
BR0209932A (pt) *	2001-05-22	2004-10-13	Neurogen Corp	Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
WO2002102778A1 (fr) *	2001-06-15	2002-12-27	Yamanouchi Pharmaceutical Co., Ltd.	Derive de phenylpyridinecarbonylpiperazine
JP4186518B2 (ja) *	2001-06-15	2008-11-26	アステラス製薬株式会社	フェニルピリジン誘導体
UY27450A1 (es) *	2001-09-24	2003-04-30	Bayer Corp	Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
CA2468716A1 (fr)	2001-11-28	2003-06-05	Fujisawa Pharmaceutical Co., Ltd.	Composes d'amide heterocycliques en tant qu'inhibiteurs de l'apolipoproteine b
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
JP4291696B2 (ja) *	2002-01-22	2009-07-08	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	２−（ピリジン−２−イルアミノ）−ピリド［２，３−ｄ］ピリミジン−７−オン
CN1305850C (zh)	2002-03-13	2007-03-21	詹森药业有限公司	作为组蛋白脱乙酰酶新颖抑制剂的磺酰基氨基衍生物
OA12790A (en)	2002-03-13	2006-07-10	Janssen Pharmaceutica Nv	New inhibitors of histone deacetylase.
MXPA04010555A (es) *	2002-04-25	2005-02-17	Pharmacia Corp	Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
WO2004065378A1 (fr)	2003-01-17	2004-08-05	Warner-Lambert Company Llc	Heterocycles 2-aminopyridines substitues utilises comme inhibiteurs de la proliferation cellulaire
US20040204422A1 (en)	2003-04-14	2004-10-14	Abbott Gmbh & Co. Kg.	N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
KR20060036105A (ko)	2003-07-29	2006-04-27	제논 파마슈티칼스 인크.	피리딜 유도체 및 그의 치료제로서의 용도
EP1651606B1 (fr) *	2003-07-30	2012-10-24	Xenon Pharmaceuticals Inc.	Derives pyridyle et leur utilisation en tant qu'agents therapeutiques
GT200600046A (es) *	2005-02-09	2006-09-25		Terapia de combinacion

2004
- 2004-07-29 KR KR1020067002001A patent/KR20060036105A/ko not_active Ceased
- 2004-07-29 MX MXPA06001202A patent/MXPA06001202A/es active IP Right Grant
- 2004-07-29 CA CA002533898A patent/CA2533898A1/fr not_active Abandoned
- 2004-07-29 AT AT04779556T patent/ATE556056T1/de active
- 2004-07-29 JP JP2006522073A patent/JP4884219B2/ja not_active Expired - Fee Related
- 2004-07-29 ES ES04779556T patent/ES2386354T3/es not_active Expired - Lifetime
- 2004-07-29 WO PCT/US2004/024542 patent/WO2005011654A2/fr not_active Ceased
- 2004-07-29 US US10/566,857 patent/US7763618B2/en not_active Expired - Fee Related
- 2004-07-29 SG SG200805639-2A patent/SG145695A1/en unknown
- 2004-07-29 AU AU2004261250A patent/AU2004261250B2/en not_active Ceased
- 2004-07-29 BR BRPI0413059-6A patent/BRPI0413059A/pt not_active IP Right Cessation
- 2004-07-29 EP EP04779556A patent/EP1651605B1/fr not_active Expired - Lifetime
2006
- 2006-01-25 EC EC2006006314A patent/ECSP066314A/es unknown
- 2006-01-26 IL IL173397A patent/IL173397A0/en unknown
- 2006-01-27 TN TNP2006000035A patent/TNSN06035A1/en unknown
- 2006-02-27 MA MA28840A patent/MA28012A1/fr unknown
- 2006-02-28 NO NO20060973A patent/NO20060973L/no not_active Application Discontinuation
2010
- 2010-06-15 US US12/816,076 patent/US8383628B2/en not_active Expired - Fee Related
2012
- 2012-09-14 US US13/620,151 patent/US20130079354A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US7763618B2 (en)	2010-07-27
US8383628B2 (en)	2013-02-26
CA2533898A1 (fr)	2005-02-10
US20130079354A1 (en)	2013-03-28
ES2386354T3 (es)	2012-08-17
TNSN06035A1 (en)	2007-10-03
MA28012A1 (fr)	2006-07-03
SG145695A1 (en)	2008-09-29
WO2005011654A3 (fr)	2005-04-14
IL173397A0 (en)	2006-06-11
AU2004261250B2 (en)	2009-02-26
WO2005011654A2 (fr)	2005-02-10
BRPI0413059A (pt)	2006-10-31
EP1651605B1 (fr)	2012-05-02
MXPA06001202A (es)	2006-08-31
AU2004261250A1 (en)	2005-02-10
JP4884219B2 (ja)	2012-02-29
ECSP066314A (es)	2006-07-28
US20100305138A1 (en)	2010-12-02
JP2007500716A (ja)	2007-01-18
KR20060036105A (ko)	2006-04-27
US20060293308A1 (en)	2006-12-28
ATE556056T1 (de)	2012-05-15
EP1651605A2 (fr)	2006-05-03

Publication	Publication Date	Title
NO20060973L (no)	2006-04-27	Pyridylderivater og deres anvendelse som tempeutiske midler
TNSN06033A1 (en)	2007-10-03	Piperazine derivatives and their use as therapeutic agents
NO20060974L (no)	2006-04-27	Pyridazinderivater og deres anvendelse som terapeutiske midler
TNSN06034A1 (en)	2007-10-03	Pyridazine derivatives and their use as therapeutic agents
TNSN06036A1 (en)	2007-10-03	Pyridyl derivatives and their use as therapeutic agents
TW200638935A (en)	2006-11-16	Pyridazine derivatives and their use as therapeutic agents
MX2007003321A (es)	2007-06-05	Derivados heterociclicos y su uso como agentes terapeuticos.
TW200624427A (en)	2006-07-16	Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626153A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626592A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626139A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626155A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626572A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
TW200626148A (en)	2006-08-01	Heterocyclic derivatives and their use as therapeutic agents
BRPI0418939A (pt)	2008-04-08	derivados de nicotinamida e sua utilização como agentes terapêuticos
NO20060664L (no)	2006-05-16	N-substituerte benzimidazolyl C-kit inhibitorer
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
WO2007046867A3 (fr)	2007-07-05	Derives de piperidine et leurs utilisations comme agents therapeutiques
SE0301701D0 (sv)	2003-06-10	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301699D0 (sv)	2003-06-10	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2006125194A3 (fr)	2007-01-04	Derives de piperazine et leurs utilisations en tant qu'agents therapeutiques
MY144229A (en)	2011-08-15	Pyridazine derivatives and their use as therapeutic agents
EP2266566A3 (fr)	2011-01-12	Dérivés de nicotinamide et utilisation de ceux-ci comme agents thérapeutiques
JO2829B1 (en)	2014-09-15	Pyridazine derivatives and their use as therapeutic agents

Legal Events

Date	Code	Title	Description
2008-02-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application